Neil M. Cowen
Corporate Officer/Principal bei SOLENO THERAPEUTICS, INC.
Profil
Neil M.
Cowen is the founder of Essentialis, Inc. (founded in 2003) where he held the title of President & Chief Scientific Officer.
He is currently the Senior Vice President-Drug Development at Soleno Therapeutics, Inc. since 2017 and a Member-Regents Board at Concordia University-Irvine.
In the past, he worked as a Principal at The Dow Chemical Co. and as the Vice President-Strategic Development at Epicyte Pharmaceutical, Inc. from 2001 to 2003.
Dr. Cowen's education includes an undergraduate and graduate degree from Michigan State University, a doctorate from Iowa State University, and an MBA from the University of Indianapolis.
Aktive Positionen von Neil M. Cowen
| Unternehmen | Position | Beginn |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Corporate Officer/Principal | 01.03.2017 |
| Concordia University-Irvine | Director/Board Member | - |
Ehemalige bekannte Positionen von Neil M. Cowen
| Unternehmen | Position | Ende |
|---|---|---|
Epicyte Pharmaceutical, Inc.
 Epicyte Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Epicyte Pharmaceutical, Inc. develops biopharmaceuticals. The American company was founded by Mich B. Hein. Epicyte Pharmaceutical was acquired by Biolex Therapeutics, Inc. on May 06, 2004. | Corporate Officer/Principal | 01.01.2003 |
| DOW CHEMICAL COMPANY (THE) | Corporate Officer/Principal | - |
Essentialis, Inc.
 Essentialis, Inc. Pharmaceuticals: OtherHealth Technology Essentialis, Inc. develops therapeutic products in curing metabolic diseases. It operates as a pharmaceutical company focusing on the development of breakthrough medicines for the treatment of rare metabolic diseases where there is mortality and risk of cardiovascular and endocrine complications. The company was founded by Neil M. Cowen, Jeffrey A. Staffa and Thomas A. Glaze in 2004 and is headquartered in San Diego, CA. | Founder | - |
Ausbildung von Neil M. Cowen
| Michigan State University | Graduate Degree |
| Iowa State University | Doctorate Degree |
| University of Indianapolis | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SOLENO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
The Dow Chemical Co.
 The Dow Chemical Co. Chemicals: SpecialtyProcess Industries The Dow Chemical Co. engages in the manufacture and distribution of chemicals, plastics, industrial and agricultural products. It serves agriculture, automotive, building and construction, consumer, electronic materials, infrastructure, packaging, product finder and product safety industries. The company was founded by Herbert Henry Dow in 1897 and is headquartered in Midland, MI. | Process Industries |
Epicyte Pharmaceutical, Inc.
Epicyte Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Epicyte Pharmaceutical, Inc. develops biopharmaceuticals. The American company was founded by Mich B. Hein. Epicyte Pharmaceutical was acquired by Biolex Therapeutics, Inc. on May 06, 2004. | Health Technology |
Essentialis, Inc.
Essentialis, Inc. Pharmaceuticals: OtherHealth Technology Essentialis, Inc. develops therapeutic products in curing metabolic diseases. It operates as a pharmaceutical company focusing on the development of breakthrough medicines for the treatment of rare metabolic diseases where there is mortality and risk of cardiovascular and endocrine complications. The company was founded by Neil M. Cowen, Jeffrey A. Staffa and Thomas A. Glaze in 2004 and is headquartered in San Diego, CA. | Health Technology |
